

About Us
Our Mission
Vetana’s mission is to improve the lives of animals who suffer from inflammatory diseases. Our therapy supports the intrinsic mechanisms already present in the body to control inflammation. Our lead program delivers Interleukin-10, nature’s own anti-inflammatory agent, directly into areas of inflammation such as joints with osteoarthritis. Reducing joint inflammation leads to less pain and improved mobility.
We are a team of drug development experts with decades of experience in bringing new products to patients. We share a deep passion for the well-being of animals and are devoted to working on novel therapies that we hope will make meaningful improvements in their lives.
Meet The Team

Steve Collins, M.D., Ph.D.
President and Executive Chairman

Gary Massengill
Director, Product Development and Regulatory
(PBM Capital Group)

Ray Chavez, Ph.D.
VP, Research & Development

Shannon Hall
Project Management
(PBM Capital Group)

Jayson Rieger
Chief Operating Officer

David Glover
Director, Research and Development
(PBM Capital Group)
Our Board of Directors

Paul Manning

Sean Stalfort

Stephen D. Collins,
MD, Ph.D.

Jayson Rieger, Ph.D., MBA